Tables 2 and 3 provide additional insight by demonstrating that specific potential risk factors associated with GBM, including age, gender, tumor count, tumor resection size, IDH1 gene status, and MGMT gene methylation status, did not exhibit significant associations with the CDKN1A genotype. This evidence concerns the gene CDKN1A and glioblastoma.